Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Uvistat lipscreen SPF 50
130801000BBNQA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | 269 |
|
Voltarol 50mg suppositories
1001010C0BBAJAU
|
Voltarol (Systemic) | Diclofenac sodium | Musculoskeletal and Joint Diseases | 269 |
|
CarboFlex dressing 15cm x 20cm
20031000017
|
CarboFlex dressing 15cm x 20cm | Wound Management & Other Dressings | Dressings | 268 |
|
Carob seed flour powder
0913161A0AAAGAG
|
Powder thickener - gum based (0913161) | Powder thickener - gum based (0913161) | Nutrition and Blood | 268 |
|
Confidence BE ileostomy bag with filter and overlap, mini 13-55mm stone
23604106512
|
Confidence BE ileostomy bag with filter and overlap, mini 13-55mm stone | Ileostomy Bags | Stoma Appliances | 268 |
|
Doxazosin 4mg/5ml oral solution
0205040D0AAAXAX
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | 268 |
|
Feldene Melt 20mg tablets
1001010R0BBAGAG
|
Feldene (Systemic) | Piroxicam | Musculoskeletal and Joint Diseases | 268 |
|
L-Mesitran ointment dressing
20030300028
|
L-Mesitran ointment dressing | Wound Management & Other Dressings | Dressings | 268 |
|
Pentosan polysulfate sodium 100mg capsules
0208020I0AAAGAG
|
Pentosan polysulfate sodium (Oral) | Pentosan polysulfate sodium | Cardiovascular System | 268 |
|
SenSura Mio deep convex urostomy bag maxi 10-23mm transparent
23961009707
|
SenSura Mio deep convex urostomy bag maxi 10-23mm transparent | Urostomy Bags | Stoma Appliances | 268 |
|
Verapamil 40mg/5ml oral solution sugar free
0206020T0AAAVAV
|
Verapamil hydrochloride | Verapamil hydrochloride | Cardiovascular System | 268 |
|
Azithromycin 15mg/g eye dps 0.25g ud preservative free
1103010AIAAAAAA
|
Azithromycin (Eye) | Azithromycin | Eye | 267 |
|
Coal tar 6% cream
1305020C0AABCBC
|
Coal tar/tar (Topical) | Tars | Skin | 267 |
|
Flunarizine 5mg capsules
0406000E0AAAAAA
|
Flunarizine dihydrochloride | Flunarizine dihydrochloride | Central Nervous System | 267 |
|
Glucoject No-dol lancets 0.315mm/30 gauge
21010900636
|
Glucoject No-dol lancets 0.315mm/30 gauge | Other Appliances | Appliances | 267 |
|
Mariosea XL 2mg capsules
0704020N0BDABAI
|
Mariosea XL | Tolterodine | Obstetrics, Gynaecology and Urinary-Tract Disorders | 267 |
|
Mediven Plus class 1 (18-21mmHg) below knee open toe petite
21270000222
|
Mediven Plus class 1 (18-21mmHg) below knee open toe petite | Lymphoedema Garments | Appliances | 267 |
|
Siltape 4cm
20100000708
|
Siltape 4cm | Surgical Adhesive Tape | Dressings | 267 |
|
Sodium valproate 750mg MR gran sachets sugar free
0408010W0AABYBY
|
Sodium valproate | Sodium valproate | Central Nervous System | 267 |
|
4SURE hypodermic insulin needles for pre-filled / reusable pen injectors screw on 6mm/32gauge
21010900943
|
4SURE hypodermic insulin needles for pre-filled / reusable pen injectors screw on 6mm/32gauge | Other Appliances | Appliances | 266 |
|
Cellona Undercast padding bandage 15cm x 2.7m
20020200917
|
Cellona Undercast padding bandage 15cm x 2.7m | Arm Sling/Bandages | Dressings | 266 |
|
Dexamethasone 1mg tablets
0603020G0AACNCN
|
Dexamethasone (Systemic) | Dexamethasone | Endocrine System | 266 |
|
Fexofenadine 180mg/5ml oral suspension
0304010E0AAAHAH
|
Fexofenadine hydrochloride | Fexofenadine hydrochloride | Respiratory System | 266 |
|
Fresubin HP Energy liquid
0914011I0BBAAAB
|
Fresubin tube feed 1.5 kcal/ml higher protein | Tube feed 1.5 kcal/ml higher protein (0914011) | Nutrition and Blood | 266 |
|
Hyoscine butylbromide 10mg/5ml oral solution
0102000N0AAAPAP
|
Hyoscine butylbromide | Hyoscine butylbromide | Gastro-Intestinal System | 266 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.